TITLE

New testing standards help to detect prostate cancer in black men earlier and more accurately

PUB. DATE
August 1996
SOURCE
Jet;08/19/96, Vol. 90 Issue 14, p22
SOURCE TYPE
Periodical
DOC. TYPE
Article
ABSTRACT
Relates that findings from a study will enhance doctors' abilities to diagnose prostate cancer in black men. The study giving the first prostatic specific antigen (PSA) levels specifically for black men; Fact that black men have a higher risk of suffering from prostate cancer than white men; Research by Dr. Judd Moul and reported in the New England Journal of Medicine.
ACCESSION #
9608237904

 

Related Articles

  • Kinder test for prostate cancer. S.M. // Arthritis Today;Sep/Oct98, Vol. 12 Issue 5, p16 

    Presents information on the Free PSA test for prostate cancer. Effectiveness of the test; Approval of the test; Comments from Kevin Slawin, medical doctor, who studied the test and is director of the Baylor Prostate Center in Houston, Texas.

  • ACC Adds New Early Detection Test. AUER, TONIE // Business Press;10/02/98, Vol. 11 Issue 21, p4 

    Reports that the Arlington Cancer Center in Arlington, Texas is offering the Bayer Immuno 1 Complexed Prostate Specific Antigen Assay, a tool to help detect prostate cancer in its earliest stages. Importance of early diagnosis; Description of the prostate cancer test; Total financial investment...

  • Prostate screening to be discouraged. Prenesti, Sam // Australian Nursing Journal;Sep96, Vol. 4 Issue 3, p10 

    Cites the results of a report compiled by the Australian Health Technology Advisory Committee which found that screening for prostate cancer were unreliable and could cause more harm than good. Lack of consensus among the medical professions about the effectiveness of screening tests;...

  • Gleason score can predict risk of death from prostate cancer in some men.  // Modern Medicine;Jan99, Vol. 67 Issue 1, p48 

    Discusses the abstract `Competing Risk Analysis of Men Aged 55 to 74 Years at Diagnosis Managed Conservatively for Clinically Localized Prostate Cancer' by P.C. Albertsen, J.A. Hanley, et al., published in the September 16, 1998 issue of the `Journal of American Medical Association' periodical.

  • Validation of the group-based medical mistrust scale among urban black men. Shelton, Rachel C.; Winkel, Gary; Davis, Stacy N.; Roberts, Nicole; Valdimarsdottir, Heiddis; Hall, Simon J.; Thompson, Hayley S. // JGIM: Journal of General Internal Medicine;Jun2010, Vol. 25 Issue 6, p549 

    Background: Socioculturally relevant measures of medical mistrust are needed to better address health disparities, especially among Black men, a group with lower life expectancy and higher death rates compared to other race/gender groups.Objectives: The study aim was to...

  • FACTORS INFLUENCING PROSTATE CANCER. SINGH, SANDEEP; RAGUVARAN, R.; RAJKUMAR, K. // International Journal of Pharmacy & Pharmaceutical Sciences;2014, Vol. 6 Issue 6, p33 

    Prostate Cancer is the second most frequently diagnosed cancer and the sixth leading cause of cancer death in males. It accounts for 14% of the total new cancer cases and 6% of the total cancer deaths in males in 2008 [1]. The incidence and mortality rates were different in diverse geographic...

  • You Be the Coder.  // Internal Medicine Coding Alert;Jun2010, Vol. 13 Issue 6, pp45 

    The article provides an answer to a question on the consideration of other factors besides ICD-9 and Current Procedural Terminology (CPT) in case of denial of reimbursement claim for prostate cancer screening.

  • The Problems with Prostate Cancer.  // State Legislatures;Dec98, Vol. 24 Issue 10, p8 

    Reports on the issue on the necessity for insurance companies to regularly screen their clients for prostate cancer. Cost of mass screening according to the United States Preventive Services Task Force; States that require insurers to cover yearly prostate cancer screening for all men over age 50.

  • 155-6. THE DILEMMA OVER PSA SCREENING.  // Cortlandt Forum;01/25/2001, Vol. 14 Issue 1, p80 

    Discusses an appropriate screening strategy for prostate-specific antigen (PSA). Controversy surrounding serum PSA testing as a screening tool for prostate cancer; Need for a screening test to identify disease sufficiently early in its course; Clinicians' adoption of a program of annual testing...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics